The CellSearch™ Circulating Tumor Cell (CTC) Test from Veridex is a simple blood test that captures and assesses CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer at any time. The test provides an objective, quantitative, real-time reading of tumor information so that oncologists can provide optimum care for their patients.